Drugs / LH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01563809 Comparator | Dec 2008 → Dec 2010 | female infertility | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01563809 ↗ |
| Known as | r-LH | “They are randomized to receive recombinant (r) FSH alone (225 IU/day) or r-FSH + r-LH (225+75 IU/day).” NCT01563809 ↗ |